Lawrence H Schwartz

Lawrence H Schwartz

UNVERIFIED PROFILE

Are you Lawrence H Schwartz?   Register this Author

Register author
Lawrence H Schwartz

Lawrence H Schwartz

Publications by authors named "Lawrence H Schwartz"

Are you Lawrence H Schwartz?   Register this Author

100Publications

2975Reads

19Profile Views

Automatic liver segmentation by integrating fully convolutional networks into active contour models.

Med Phys 2019 Oct 16;46(10):4455-4469. Epub 2019 Aug 16.

Department of Radiology, Columbia University Medical Center, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mp.13735DOI Listing
October 2019

Radiomics for Classification of Lung Cancer Histological Subtypes Based on Nonenhanced Computed Tomography.

Acad Radiol 2019 Sep 28;26(9):1245-1252. Epub 2018 Nov 28.

Department of Radiology, Columbia University Medical Center, 630 West 168th Street, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2018.10.013DOI Listing
September 2019

Application of Radiomics in Predicting the Malignancy of Pulmonary Nodules in Different Sizes.

AJR Am J Roentgenol 2019 Sep 26:1-8. Epub 2019 Sep 26.

Department of Radiology, New York Presbyterian Hospital, Columbia University Medical Center, 622 W 168th St, New York, NY 10032.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.19.21490DOI Listing
September 2019

Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.

Eur Radiol 2019 Aug 23. Epub 2019 Aug 23.

Department of Radiology, New York Presbyterian Hospital, Columbia University Vagelos College of Physicians and Surgeons, New York City, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-019-06347-wDOI Listing
August 2019

Automated Identification of Optimal Portal Venous Phase Timing with Convolutional Neural Networks.

Acad Radiol 2019 May 28. Epub 2019 May 28.

Department of Radiology, Columbia University Medical Center, 630 West 168th Street, New York, NY 10032.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2019.02.024DOI Listing
May 2019

Radiomics for Classifying Histological Subtypes of Lung Cancer Based on Multiphasic Contrast-Enhanced Computed Tomography.

J Comput Assist Tomogr 2019 Mar/Apr;43(2):300-306

Department of Radiology, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527094PMC
April 2019

CT-Based Radiomics Model for Predicting Brain Metastasis in Category T1 Lung Adenocarcinoma.

AJR Am J Roentgenol 2019 Apr 1:1-6. Epub 2019 Apr 1.

2 Department of Radiology, NewYork-Presbyterian Hospital, Columbia University Medical Center, 630 W 168th St, New York, NY 10032.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.18.20591DOI Listing
April 2019

Artificial intelligence in cancer imaging: Clinical challenges and applications.

CA Cancer J Clin 2019 Mar 5;69(2):127-157. Epub 2019 Feb 5.

Associate Professor, Departments of Radiation Oncology and Radiology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403009PMC
March 2019

A Web-Based Response-Assessment System for Development and Validation of Imaging Biomarkers in Oncology.

Tomography 2019 03;5(1):220-225

Department of Radiology, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18383/j.tom.2019.00006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403026PMC
March 2019

Sorafenib for Advanced and Refractory Desmoid Tumors.

N Engl J Med 2018 12;379(25):2417-2428

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center (M.M.G., W.D.T., N.H., N.P.A., R.A.L., Y.M., R.Y.) and Columbia University Vagellos College of Physicians and Surgeons and New York Presbyterian Hospital (L.H.S., G.K.S.), New York, and Northwell Cancer Institute and Cold Spring Harbor Laboratory, Lake Success (R.G.M.) - all in New York; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (M.R.M.); Washington University School of Medicine, St. Louis (B.A.V.T.); M.D. Anderson Cancer Center, University of Texas, Houston (V.R.); Mayo Clinic in Florida, Jacksonville (S.A.); Yale University, New Haven, CT (H.A.D.); University Health Network Princess Margaret Cancer Centre, Toronto (A.A.G.); University of Iowa-Holden Comprehensive Cancer Center, Iowa City (M.M.M.); University of Alabama at Birmingham Cancer Center, Birmingham (R.M.C.); Fox Chase Cancer Center, Philadelphia (S.M.); Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC (M.J.P.); Duke Cancer Institute, Duke University Medical Center, Durham (R.F.R.), and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill (E.B.) - both in North Carolina; Dayton National Cancer Institute Community Oncology Research Program, Dayton, OH (T.S.); National Cancer Institute, Bethesda, MD (J.J.W.); and the Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ (A.C.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447029PMC
December 2018

Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology.

JCO Clin Cancer Inform 2018 12;2:1-12

Laurent Dercle, Binsheng Zhao, and Lawrence H. Schwartz, Columbia University Medical Center and New York Presbyterian Hospital; Mithat Gönen, Patrick Hilden, and Chaya S. Moskowitz, Memorial Sloan Kettering Cancer Center, New York, NY; Dana E. Connors and Stacey J. Adam, Foundation for the National Institutes of Health, North Bethesda, MD; Ying Tang, CCS Associates, San Jose, CA; Sanja Karovic and Michael Maitland, Inova Schar Cancer Institute, Fairfax, VA; Gary Kelloff, National Cancer Institute, Rockville, MD; and Geoffrey R. Oxnard, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/CCI.17.00137
Publisher Site
http://dx.doi.org/10.1200/CCI.17.00137DOI Listing
December 2018

Artificial intelligence in radiology.

Nat Rev Cancer 2018 08;18(8):500-510

Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41568-018-0016-5
Publisher Site
http://dx.doi.org/10.1038/s41568-018-0016-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268174PMC
August 2018

Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study.

Cancer Chemother Pharmacol 2018 07 26;82(1):49-54. Epub 2018 Apr 26.

Pharsight Consulting Services, Pharsight, a Certara™ Company, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3587-7DOI Listing
July 2018

Lymph node segmentation by dynamic programming and active contours.

Med Phys 2018 May 1;45(5):2054-2062. Epub 2018 Apr 1.

Department of Radiology, Columbia University Medical Center, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mp.12844DOI Listing
May 2018

Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma.

Eur J Cancer 2018 03;91:136-144

Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Gustave Roussy, Université Paris-Saclay, Département D'hématologie, Villejuif F-94805, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.015DOI Listing
March 2018

Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab.

Neuro Oncol 2017 Nov;19(12):1688-1697

Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA; Product Development, Pharma Division, F. Hoffmann-La Roche Ltd., Basel, Switzerland; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA; Department of Radiology, Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, New York, USA.

View Article

Download full-text PDF

Source
http://academic.oup.com/neuro-oncology/article/19/12/1688/38
Publisher Site
http://dx.doi.org/10.1093/neuonc/nox092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716072PMC
November 2017

Impact of Variability in Portal Venous Phase Acquisition Timing in Tumor Density Measurement and Treatment Response Assessment: Metastatic Colorectal Cancer as a Paradigm.

JCO Clin Cancer Inform 2017 11;1:1-8

Laurent Dercle, Lin Lu, Philip Lichtenstein, Hao Yang, Jianguo Zhu, Feiyun Wu, Lawrence H. Schwartz, and Binsheng Zhao, Columbia University Medical Center, and Presbyterian Hospital, New York, NY; Laurent Dercle, Gustave Roussy, Université Paris-Saclay, UMR1015, Villejuif, France; Deling Wang, Sun Yat-sen University Cancer Center; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong; State Key Laboratory of Oncology in South China, Hong Kong, Special Administrative Region, People's Republic of China; and Hubert Piessevaux, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.17.00108DOI Listing
November 2017

Assessing Agreement between Radiomic Features Computed for Multiple CT Imaging Settings.

PLoS One 2016 29;11(12):e0166550. Epub 2016 Dec 29.

Department of Radiology, Columbia University Medical Center, New York, NY, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0166550PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199063PMC
July 2017

Radiomic Analysis using Density Threshold for FDG-PET/CT-Based N-Staging in Lung Cancer Patients.

Mol Imaging Biol 2017 04;19(2):315-322

Department of Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-016-0996-zDOI Listing
April 2017

Correlation Between SUVmax and CT Radiomic Analysis Using Lymph Node Density in PET/CT-Based Lymph Node Staging.

J Nucl Med 2017 Feb 22;58(2):282-287. Epub 2016 Sep 22.

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.179648DOI Listing
February 2017

Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.

J Clin Oncol 2017 01 23;35(2):258-259. Epub 2016 Oct 23.

Karen T. Brown and Richard Do, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Mithat Gönen, Memorial Sloan Kettering Cancer Center, New York, NY; Anne M. Covey, George I. Getrajdman, and Constantinos T. Sofocleous, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; William R. Jarnagin, Michael I. D'Angelica, and Peter J. Allen, Memorial Sloan Kettering Cancer Center, Columbia University College of Physicians and Surgeons, and Weill Cornell Medical College, New York, NY; Joseph P. Erinjeri and Lynn A. Brody, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Gerald P. O'Neill, Kristian Johnson, Alessandra R. Garcia, and Christopher M. Beattie, Memorial Sloan Kettering Cancer Center, New York, NY; Binsheng Zhao, Columbia University College of Physicians and Surgeons, New York, NY; Stephen B. Solomon, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Lawrence H. Schwartz, Columbia University College of Physicians and Surgeons, New York, NY; Ronald P. DeMatteo, Memorial Sloan Kettering Cancer Center, Columbia University College of Physicians and Surgeons, and Weill Cornell Medical College, New York, NY; and Ghassan K. Abou-Alfa, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.7961DOI Listing
January 2017

A Response Assessment Platform for Development and Validation of Imaging Biomarkers in Oncology.

Tomography 2016 Dec;2(4):406-410

Department of Radiology, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18383/j.tom.2016.00223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037929PMC
December 2016

Volumetry of low-contrast liver lesions with CT: Investigation of estimation uncertainties in a phantom study.

Med Phys 2016 Dec;43(12):6608

Division of Imaging, Diagnostics and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland 20993.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.4967776DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123997PMC
December 2016

High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy.

J Hematol Oncol 2016 11 30;9(1):132. Epub 2016 Nov 30.

Center for Lymphoid Malignancies, Division of Hematology/Oncology, Department of Medicine, Columbia University Medical Center, 51 West 51st Street, Suite 200, New York, NY, 10019, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0363-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129196PMC
November 2016

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.

J Clin Oncol 2016 Oct;34(30):3680-3685

Vadim S. Koshkin, Cleveland Clinic, Cleveland, OH; Vanessa Bolejack, Cancer Research and Biostatistics, Seattle, WA; Lawrence H. Schwartz, Binsheng Zhao, Columbia University Medical Center, New York, NY; Richard L. Wahl, Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, MO; Rashmi Chugh, Scott M. Schuetze, Laurence H. Baker, University of Michigan Medical School; Denise K. Reinke, Sarcoma Alliance for Research Through Collaboration, Ann Arbor, MI; Joo H. O, The Catholic University of Korea; Seoul St Mary's Hospital, Seoul, Republic of Korea; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.1858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065114PMC
October 2016

Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC.

Sci Rep 2016 09 20;6:33860. Epub 2016 Sep 20.

Departments of Radiology Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep33860DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028716PMC
September 2016

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.

J Clin Oncol 2016 06 1;34(17):2046-53. Epub 2016 Feb 1.

Karen T. Brown, Richard K. Do, Mithat Gonen, Anne M. Covey, George I. Getrajdman, Constantinos T. Sofocleous, William R. Jarnagin, Michael I. D'Angelica, Peter J. Allen, Joseph P. Erinjeri, Lynn A. Brody, Gerald P. O'Neill, Kristian N. Johnson, Alessandra R. Garcia, Christopher Beattie, Stephen B. Solomon, Ronald DeMatteo, and Ghassan K. Abou-Alfa, Memorial Sloan Kettering Cancer Center; Binsheng Zhao and Lawrence H. Schwartz, Columbia University College of Physicians and Surgeons; and Karen T. Brown, Richard K. Do, Anne M. Covey, George I. Getrajdman, Constantinos T. Sofocleous, William R. Jarnagin, Michael I. D'Angelica, Peter J. Allen, Joseph P. Erinjeri, Lynn A. Brody, Stephen B. Solomon, Ronald DeMatteo, and Ghassan K. Abou-Alfa, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.0821DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966514PMC
June 2016

Response Rate as a Regulatory End Point in Single-Arm Studies of Advanced Solid Tumors.

JAMA Oncol 2016 Jun;2(6):772-9

Department of Radiology, Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.6315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574183PMC
June 2016

Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.

J Thorac Oncol 2016 06 8;11(6):890-9. Epub 2016 Mar 8.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.02.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877255PMC
June 2016

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.

J Clin Oncol 2016 Apr 22;34(12):1402-18. Epub 2016 Feb 22.

Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.2702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872347PMC
April 2016

Reproducibility of radiomics for deciphering tumor phenotype with imaging.

Sci Rep 2016 Mar 24;6:23428. Epub 2016 Mar 24.

Department of Radiology, Columbia University Medical Center, 710 West 168th Street, New York NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep23428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806325PMC
March 2016

Do Radiologists Have Stage Fright? Tumor Staging and How We Can Add Value to the Care of Patients with Cancer.

Radiology 2016 Jan;278(1):11-2

From the Departments of Radiology of the University of California-San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 (C.M.G.); University of Texas-MD Anderson Cancer Center, Houston, Tex (P.R.B., J.J.E.); National Cancer Institute, Bethesda, Md (P.L.C.); Emory University Hospital, Atlanta, Ga (C.J.D.); Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (R.R.G.); Michigan State University, East Lansing, Mich (S.K.M.); Memorial Sloan-Kettering Cancer Center, New York, NY (D.M.P.); Columbia University Medical Center, New York, NY (L.H.S.); Johns Hopkins Medical Institutions, Baltimore, Md (R.M.S.); and Duke University Medical Center, Durham, NC (D.C.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2015151563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699490PMC
January 2016

Semiautomatic segmentation of liver metastases on volumetric CT images.

Med Phys 2015 Nov;42(11):6283-93

Department of Radiology, Columbia University Medical Center, 630 West 168th Street, New York, New York 10032.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.4932365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600084PMC
November 2015

Hybrid detection of lung nodules on CT scan images.

Med Phys 2015 Sep;42(9):5042-54

Department of Radiology, Columbia University Medical Center, 630 West 168th Street, New York, New York 10032.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.4927573DOI Listing
September 2015

Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to (68)Ga-DOTATOC PET.

Eur J Radiol 2015 Aug 8;84(8):1593-1600. Epub 2015 May 8.

University Hospital Heidelberg, Department of Nuclear Medicine, INF 400, 69120 Heidelberg, Germany; Department of Radiology, Columbia University College of Physicians and Surgeons, USA; New York Presbyterian Hospital, 630 West 168th Street, New York, NY 10032, USA; German Cancer Research Center (dkfz), Clinical Cooperations Unit Nuclear Medicine, INF 280, 69120 Heidelberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0720048X150018
Publisher Site
http://dx.doi.org/10.1016/j.ejrad.2015.04.009DOI Listing
August 2015

Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography.

Oncologist 2015 Aug 14;20(8):890-5. Epub 2015 Jul 14.

Centre Universitaire Hospitalier Henri Mondor, Lymphoma Study Association Imaging, Créteil, France; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Columbia University Medical Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524767PMC
August 2015

MR/ultrasound fusion-guided biopsy in prostate cancer: what is the evidentiary standard?

JAMA 2015 Jan;313(4):367-8

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill4Associate Editor, JAMA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.17943DOI Listing
January 2015

Exploring Variability in CT Characterization of Tumors: A Preliminary Phantom Study.

Transl Oncol 2014 Feb 1;7(1):88-93. Epub 2014 Feb 1.

Department of Radiology, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000020PMC
http://dx.doi.org/10.1593/tlo.13865DOI Listing
February 2014

Response phenotype as a predictive biomarker to guide treatment with targeted therapies.

J Clin Oncol 2013 Oct 16;31(30):3739-41. Epub 2013 Sep 16.

Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.8365DOI Listing
October 2013

Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.

Radiology 2013 Jul 6;268(1):254-64. Epub 2013 Mar 6.

Department of Radiology, Seoul National University Hospital, 28 Yeongeon-dong, Chongno-gu, Seoul 110-744, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.13112553DOI Listing
July 2013

The imaging viewpoint: how imaging affects determination of progression-free survival.

Clin Cancer Res 2013 May;19(10):2621-8

Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2936DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654392PMC
May 2013

Segmentation of lung lesions on CT scans using watershed, active contours, and Markov random field.

Med Phys 2013 Apr;40(4):043502

Department of Radiology, Columbia University Medical Center, 630 West 168th Street, New York, New York 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.4793409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618093PMC
April 2013

When progressive disease does not mean treatment failure: reconsidering the criteria for progression.

J Natl Cancer Inst 2012 Oct 27;104(20):1534-41. Epub 2012 Aug 27.

Dana-Farber Cancer Institute, 450 Brookline Ave., Dana 1234, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708548PMC
October 2012

Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes.

Radiology 2012 Sep 24;264(3):779-88. Epub 2012 Jul 24.

Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room C-278E, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.12110746DOI Listing
September 2012